Flj20647s as modifiers of the p21 pathway and methods of use

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) A61K 39/395 (2006.01) A61K 45/00 (2006.01) C07K 14/47 (2006.01) C12Q 1/00 (2006.01) G01N 33/50 (2006.01) G01N 33/53 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2497793

Human FLJ20647 genes are identified as modulators of the p21 pathway, and thus are therapeutic targets for disorders associated with defective p21 function. Methods for identifying modulators of p21, comprising screening for agents that modulate the activity of FLJ20647 are provided.

L'invention concerne des gènes humains FL20647 identifiés en tant que modulateurs de la voie p21 et les cibles thérapeutiques pour des troubles sont associées à un dysfonctionnement de la p21. L'invention concerne également de procédés d'identification de modulateurs de la p21, comprenant le criblage d'agents qui modulent l'activité de FLJ20647.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Flj20647s as modifiers of the p21 pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Flj20647s as modifiers of the p21 pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Flj20647s as modifiers of the p21 pathway and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1930462

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.